Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2007

01-11-2007 | Brief Report

Candidemia complicated by endophthalmitis: a prospective analysis

Authors: S. Kannangara, D. Shindler, D. Y. Kunimoto, B. Sell, J. A. DeSimone

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2007

Login to get access

Excerpt

Endogenous fungal endophthalmitis, including chorioretinitis or vitreal involvement, is a known complication of disseminated candidal infection. The incidence rate of candidal eye infection as a complication of candidemia is unclear. Some studies of ocular candidiasis, many of which were performed retrospectively, report rates varying from 2% to 40% [17]. This variability in incidence may relate to the retrospective nature of these reports, a difference in definition of ocular candidiasis, or other differences in methodology. A few prospective studies report similar rates ranging from approximately 2% to 40% [14, 6, 810]. Therefore, to demonstrate the current incidence of ocular candidiasis, we undertook a prospective study of fungal endophthalmitis as a complication of candidemia in hospitalized patients. …
Literature
1.
go back to reference Krishna R, Amuh D, Lowder CY, Gordon SM, Adal KA, Hall G (2000) Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis? Eye 14:30–34PubMed Krishna R, Amuh D, Lowder CY, Gordon SM, Adal KA, Hall G (2000) Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis? Eye 14:30–34PubMed
2.
go back to reference Brooks RG (1989) Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 149:2226–2228PubMedCrossRef Brooks RG (1989) Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 149:2226–2228PubMedCrossRef
3.
go back to reference Feman SS, Nichols JC, Chung SM, Theobald TA (2002) Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc 100:67–71.PubMed Feman SS, Nichols JC, Chung SM, Theobald TA (2002) Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc 100:67–71.PubMed
4.
go back to reference Parke DW, Jones DB, Gentry LO (1982) Endogenous endophthalmitis among patients with candidemia. Ophthalmology 89:789–796PubMed Parke DW, Jones DB, Gentry LO (1982) Endogenous endophthalmitis among patients with candidemia. Ophthalmology 89:789–796PubMed
5.
go back to reference Henderson DK, Edwards JE, Montgomerie JZ (1981) Hematogenous candida endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis 143:655–661PubMed Henderson DK, Edwards JE, Montgomerie JZ (1981) Hematogenous candida endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis 143:655–661PubMed
6.
go back to reference Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE, Wagener MW, Yu VL (1994) Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 101:1302–1309PubMed Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE, Wagener MW, Yu VL (1994) Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 101:1302–1309PubMed
7.
go back to reference McDonnell PJ, McDonnell JM, Brown RH, Green WR (1985) Ocular involvement in patients with fungal infections. Ophthalmology 92:706–709PubMed McDonnell PJ, McDonnell JM, Brown RH, Green WR (1985) Ocular involvement in patients with fungal infections. Ophthalmology 92:706–709PubMed
8.
go back to reference Rodriguez-Adrian LJ, King RT, Tamayo-Derat LG, Miller JW, Garcia CA, Rex JH (2003) Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology. Medicine 82:187–202PubMedCrossRef Rodriguez-Adrian LJ, King RT, Tamayo-Derat LG, Miller JW, Garcia CA, Rex JH (2003) Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology. Medicine 82:187–202PubMedCrossRef
9.
go back to reference Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD; the Candidemia Study Group, the National Institute of Allergy and Infectious Diseases Mycoses Study Group (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325–1330PubMedCrossRef Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD; the Candidemia Study Group, the National Institute of Allergy and Infectious Diseases Mycoses Study Group (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325–1330PubMedCrossRef
10.
go back to reference Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J; the Caspofungin Invasive Candidiasis Study Group (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347:2020–2029PubMedCrossRef Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J; the Caspofungin Invasive Candidiasis Study Group (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347:2020–2029PubMedCrossRef
11.
go back to reference Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26:404–413CrossRef Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26:404–413CrossRef
12.
go back to reference Joshi N, Hamory BH (1991) Endophthalmitis caused by non-albicans species of Candida. Rev Infect Dis 13:281–287PubMed Joshi N, Hamory BH (1991) Endophthalmitis caused by non-albicans species of Candida. Rev Infect Dis 13:281–287PubMed
13.
go back to reference Edwards JE Jr, Montgomerie JZ, Ishida K, Morrison JO, Guze LB (1977) Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity. J Infect Dis 135:294–297PubMed Edwards JE Jr, Montgomerie JZ, Ishida K, Morrison JO, Guze LB (1977) Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity. J Infect Dis 135:294–297PubMed
14.
go back to reference Rex JH, Walsh TJ, Sobel JD, Fill SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678PubMedCrossRef Rex JH, Walsh TJ, Sobel JD, Fill SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678PubMedCrossRef
Metadata
Title
Candidemia complicated by endophthalmitis: a prospective analysis
Authors
S. Kannangara
D. Shindler
D. Y. Kunimoto
B. Sell
J. A. DeSimone
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2007
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0372-7

Other articles of this Issue 11/2007

European Journal of Clinical Microbiology & Infectious Diseases 11/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.